Albano, D.; Pasinetti, N.; Dondi, F.; Giubbini, R.; Tucci, A.; Bertagna, F.
Prognostic Role of Pre-Treatment Metabolic Parameters and Sarcopenia Derived by 2-[18F]-FDG PET/CT in Elderly Mantle Cell Lymphoma. J. Clin. Med. 2022, 11, 1210.
https://doi.org/10.3390/jcm11051210
AMA Style
Albano D, Pasinetti N, Dondi F, Giubbini R, Tucci A, Bertagna F.
Prognostic Role of Pre-Treatment Metabolic Parameters and Sarcopenia Derived by 2-[18F]-FDG PET/CT in Elderly Mantle Cell Lymphoma. Journal of Clinical Medicine. 2022; 11(5):1210.
https://doi.org/10.3390/jcm11051210
Chicago/Turabian Style
Albano, Domenico, Nadia Pasinetti, Francesco Dondi, Raffaele Giubbini, Alessandra Tucci, and Francesco Bertagna.
2022. "Prognostic Role of Pre-Treatment Metabolic Parameters and Sarcopenia Derived by 2-[18F]-FDG PET/CT in Elderly Mantle Cell Lymphoma" Journal of Clinical Medicine 11, no. 5: 1210.
https://doi.org/10.3390/jcm11051210
APA Style
Albano, D., Pasinetti, N., Dondi, F., Giubbini, R., Tucci, A., & Bertagna, F.
(2022). Prognostic Role of Pre-Treatment Metabolic Parameters and Sarcopenia Derived by 2-[18F]-FDG PET/CT in Elderly Mantle Cell Lymphoma. Journal of Clinical Medicine, 11(5), 1210.
https://doi.org/10.3390/jcm11051210